OAC
CLYM

OMERS Administration Corp’s Climb Bio CLYM Stock Holding History

OMERS Administration Corp’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,700
Closed -$114K – 1165
2026
Q1 		$114K Sell
16,700
-68,766
-80% -$397K ﹤0.01% 997
2025
Q4 		$342K Buy
+85,466
New +$205K ﹤0.01% 777

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OMERS Administration Corp's CLYM Position: Q2 2026 in Review

OMERS Administration Corp sold out of Climb Bio (CLYM) in Q2 2026, closing a stake of 16,700 shares — an estimated $114K sold.

OMERS Administration Corp first reported a position in CLYM in Q4 2025 and held it in 2 quarters. The position peaked at $342K in Q4 2025. 109 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • OMERS Administration Corp reported no remaining Climb Bio position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 16,700 Climb Bio shares in Q2 2026, an estimated $114K.
  • OMERS Administration Corp first reported a position in Climb Bio in Q4 2025 and held it in 2 quarters.
  • OMERS Administration Corp's Climb Bio position peaked at $342K in Q4 2025.
  • 109 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.